VOICED : Moderna anuncia que su vacuna contra el covid-19 es eficaz en niños de 6 a 11 años

Moderna announced positive results for its COVID-19 vaccine in children aged 6-11, showing a strong immune response and a favorable safety profile. Most adverse effects were mild or moderate. Moderna plans to submit the data for global regulatory approval. Meanwhile, US advisors are set to discuss the authorization of the Pfizer-BioNTech vaccine for children aged 5-11.

What age group did Moderna's COVID-19 vaccine show positive results for?

• Children aged 12 to 15

• Children aged 6 to 11

• Children aged 3 to 5

• Children aged 16 to 18

What was the nature of most side effects observed in the clinical trials for Moderna's vaccine?

• Severe and short-term

• Severe and long-lasting

• No side effects

• Mild or moderate

How many children participated in Moderna's clinical trials for the COVID-19 vaccine?

• Over 6,000

• Over 4,700

• Over 3,000

• Over 5,000

What is Moderna's next step after obtaining positive results from their vaccine trials?

• Wait for more data

• Submit data for global regulatory approval

• Discontinue the vaccine

• Start trials for adults

Which vaccine is being discussed by U.S. advisors for children aged 5 to 11?

• Moderna

• Pfizer-BioNTech

• Johnson & Johnson

• AstraZeneca